Few of the key players in the worldwide calcium channel blocker comprise AstraZeneca Plc., Pfizer Inc., GlaxoSmithKline Plc., Bayer healthcare LLC., Johnson & Johnson, Sanofi S.A., AbMole Bioscience, Clearsynth, and Abcam.

As per the report, the worldwide calcium channel blocker market valued at USD 11.26 Billion in 2016 and is anticipated to attain USD 15.31 Billion, developing at a CAGR of about 5.4% between 2017 and 2022.

Request Free Sample Report: https://www.zionmarketresearch.com/sample/calcium-channel-blocker-market

Rising number of stress-related diseases to propel the growth of calcium channel blocker market

Calcium channel blockers (CCBs) are the chemical category of antihypertensive drugs utilized to treat numerous ill conditions of the blood vessels and heart. The varying lifestyle of individuals across all regions has resulted in a rise in the digit of stress-related disease, which, in turn, is projected to boost the growth of the calcium channel blocker market. Nevertheless, side-effects associated with calcium channel blockers such as a headache, edema, constipation, and rapid heart rate are likely to hinder the overall growth of the calcium channel blocker market.

As per a study presented at the AACR Annual Meeting 2018, calcium channel blockers, particularly the short-acting types of CCBs that are approved to treat high BP, were linked to an elevated pancreatic cancer risk in postmenopausal women.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/calcium-channel-blocker-market

Dihydropyridine segment of calcium channel blocker market to spur in the coming period

The calcium channel blocker market on the basis of the product is categorized into two types, namely, Non-Dihydropyridine and Dihydropyridine. Dihydropyridine is among the important classes of calcium channel blocker that, in 2016, were valued at around 65% of the overall calcium channel blocker market.

Dihydropyridine class is anticipated to be the biggest segment in the calcium channel blocker market owing to rising stipulation from the pharmaceutical industry. Furthermore, easy availability and low cost of the products is projected to spur the growth of the dihydropyridine segment of the calcium channel blocker market. The dihydropyridine category of calcium channel blocker market is further sub-categorized into Cilnidipine, Nifedipine, Amlodipine, Verapamil, Felodipine, Isradipine, Diltiazem, Nisoldipine, Nicardipine, and others, while the non-dihydropyridine segment is sub-categorized into Verapamil and Diltiazem.

On the basis of application, the calcium channel blocker market is classified into 5 types, namely, angina pectoris, calcium hypertension, anti-obesity, pregnancy, and other. In 2016, the hypertension segment governed the calcium channel blocker market.

Browse the full “Calcium Channel Blocker Market by Drug class (Dihydropyridine and Non-Dihydropyridine) for Hypertension, Angina Pectoris, Pregnancy, Obesity and Other – Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2016 – 2022” report at https://www.zionmarketresearch.com/report/calcium-channel-blocker-market

Calcium channel blocker market to grow in Asia Pacific region owing to increasing percentage of hypertension and obese patients

The largest share in the calcium channel blocker market is accounted by North America in terms of consumption. Furthermore, the increasing percentage of hypertension and obese patient population in the Asia Pacific region is projected to fuel the growth of the calcium channel blocker market in the coming period.

This report segments the global Calcium channel blocker as follows:

By Drug Type

  • Dihydropyridine
    • Amlodipine
    • Cilnidipine
    • Felodipine
    • Isradipine
    • Nicardipine
    • Nisoldipine
    • Nifedipine
    • Others
  • Non-Dihydropyridine
    • Diltiazem
    • Verapamil

By Application

  • Hypertension
  • Angina pectoris
  • Pregnancy
  • Anti-obesity
  • Other

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com